Medicare Represented at Least Half of the Market for 22 of the 84 Most Expensive Drugs in 2015
by
Hugues Dumont
Language: English
Release Date: February 3, 2018
In 2015, Medicare spent about $26 billion on Part B drugs, including injectable drugs, and certain cancer drugs, which are typically administered in a physician's office or hospital outpatient department. GAO was asked to examine Medicare's share of the Part B drug market. This report describes Medicare's...